Pangea
Payments companies reported to CMS as associated with Pangea. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pangea, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pangea
These are the largest totals companies reported as associated with Pangea. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Archdeacon | Cincinnati, OH | Orthopaedic Surgery | $875,329.90 |
| Michael Mckee | Phoenix, AZ | Orthopaedic Surgery | $537,013.33 |
| Robert Otoole | Baltimore, MD | Orthopaedic Trauma | $404,509.11 |
| Mark Reilly | Newark, NJ | Orthopaedic Trauma | $171,415.66 |
| Sanjit Konda | New York, NY | Orthopaedic Surgery | $170,311.49 |
| Joseph Hsu | Charlotte, NC | Orthopaedic Trauma | $167,243.48 |
| Christopher Hoshino | Torrance, CA | Orthopaedic Trauma | $158,174.89 |
| David Forsh | New York, NY | Orthopaedic Surgery | $153,784.56 |
| Hans Vanlancker | Cambridge, MA | Orthopaedic Surgery | $152,838.88 |
| Ivan Tarkin | Pittsburgh, PA | Orthopaedic Surgery | $141,665.25 |
Prescribed Pangea?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.